1. Home
  2. FENG vs PASG Comparison

FENG vs PASG Comparison

Compare FENG & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

HOLD

Current Price

$1.56

Market Cap

20.2M

Sector

Industrials

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$5.66

Market Cap

19.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FENG
PASG
Founded
1998
2017
Country
China
United States
Employees
N/A
27
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
19.2M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
FENG
PASG
Price
$1.56
$5.66
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$14.00
AVG Volume (30 Days)
8.8K
37.6K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$0.35
52 Week High
$3.65
$20.00

Technical Indicators

Market Signals
Indicator
FENG
PASG
Relative Strength Index (RSI) 39.28 50.53
Support Level N/A $4.94
Resistance Level $1.82 $5.92
Average True Range (ATR) 0.06 0.42
MACD -0.01 0.04
Stochastic Oscillator 12.50 65.65

Price Performance

Historical Comparison
FENG
PASG

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives all of its revenue from PRC.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: